Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates

Research output: Contribution to journalJournal articleResearchpeer-review

Marnix Lameijer, Tina Binderup, Mandy M. T. Van Leent, Max L. Senders, Francois Fay, Joost Malkus, Brenda L. Sanchez-gaytan, Abraham J. P. Teunissen, Nicolas Karakatsanis, Philip Robson, Xianxiao Zhou, Yuxiang Ye, Gregory Wojtkiewicz, Jun Tang, Tom T. P. Seijkens, Jeffrey Kroon, Erik S. G. Stroes, Andreas Kjaer, Jordi Ochando, Thomas Reiner & 11 others Carlos Pérez-medina, Claudia Calcagno, Edward A. Fisher, Bin Zhang, Ryan E. Temel, Filip K. Swirski, Matthias Nahrendorf, Zahi A. Fayad, Esther Lutgens, Willem J. M. Mulder, Raphaël Duivenvoorden

Original languageEnglish
JournalNature Biomedical Engineering
Volume2
Pages (from-to)279-292
DOIs
Publication statusPublished - 2018

ID: 216468062